-
EP2776441
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2776441
| EP2776441 - TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.07.2019 Database last updated on 02.08.2024 | |
| Former | Examination is in progress Status updated on 05.05.2017 | Most recent event Tooltip | 12.07.2019 | Application deemed to be withdrawn | published on 14.08.2019 [2019/33] | Applicant(s) | For all designated states Intellikine, LLC 10931 North Torrey Pines Road, Suite 103 La Jolla, CA 92037 / US | [2014/38] | Inventor(s) | 01 /
LIU, Yi 4841 Barlows Landing Cove San Diego, CA 92130 / US | 02 /
WANG, Shunyou 4172 Corte De La Siena San Diego, CA 92130 / US | 03 /
JANES, Matthew, R. 859 America Way Del Mar, CA 92014 / US | 04 /
LAN, Lucy 727 Atwood Place San Marcos, CA 92069 / US | 05 /
REN, Pingda 5534 Havenridge Way San Diego, CA 92130 / US | 06 /
ROMMEL, Christian 528 Westbourne Stree La Jolla, CA 92037 / US | [2014/38] | Representative(s) | Harris, Jennifer Lucy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2014/38] | Katzka, Catherine Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 12847122.4 | 08.11.2012 | WO2012US64239 | Priority number, date | US201161557326P | 08.11.2011 Original published format: US 201161557326 P | [2014/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013070976 | Date: | 16.05.2013 | Language: | EN | [2013/20] | Type: | A1 Application with search report | No.: | EP2776441 | Date: | 17.09.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.05.2013 takes the place of the publication of the European patent application. | [2014/38] | Search report(s) | International search report - published on: | US | 16.05.2013 | (Supplementary) European search report - dispatched on: | EP | 10.03.2015 | Classification | IPC: | A61K31/519, A61P35/00, A61K45/06 | [2015/15] | CPC: |
A61K31/519 (EP,CN,US);
A61K45/06 (EP,CN,US);
A61K31/395 (EP,CN,US);
A61K31/404 (CN,US);
A61K31/437 (CN);
A61K31/44 (CN,US);
A61K31/4412 (EP,CN,US);
A61K31/4439 (CN,US);
A61K31/506 (CN,US);
A61K31/52 (EP,CN,US);
A61K9/0053 (US);
A61P29/00 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
| C-Set: |
A61K31/404, A61K2300/00 (CN);
A61K31/437, A61K2300/00 (CN);
A61K31/4412, A61K2300/00 (US,CN,EP);
A61K31/4439, A61K2300/00 (CN);
A61K31/44, A61K2300/00 (CN);
A61K31/506, A61K2300/00 (CN); |
| Former IPC [2014/38] | C07D487/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/38] | Title | German: | BEHANDLUNGSVERFAHREN MIT MEHREREN PHARMAZEUTISCHEN MITTELN | [2014/38] | English: | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | [2014/38] | French: | RÉGIMES DE TRAITEMENT UTILISANT DE MULTIPLES AGENTS PHARMACEUTIQUES | [2014/38] | Entry into regional phase | 06.06.2014 | National basic fee paid | 06.06.2014 | Search fee paid | 06.06.2014 | Designation fee(s) paid | 06.06.2014 | Examination fee paid | Examination procedure | 06.06.2014 | Examination requested [2014/38] | 05.10.2015 | Amendment by applicant (claims and/or description) | 08.05.2017 | Despatch of a communication from the examining division (Time limit: M06) | 13.02.2018 | Reply to a communication from the examining division | 05.11.2018 | Despatch of a communication from the examining division (Time limit: M04) | 16.03.2019 | Application deemed to be withdrawn, date of legal effect [2019/33] | 09.04.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/33] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 08.05.2017 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 13.02.2018 | Request for further processing filed | 13.02.2018 | Full payment received (date of receipt of payment) Request granted | 23.02.2018 | Decision despatched | Fees paid | Renewal fee | 10.11.2014 | Renewal fee patent year 03 | 10.11.2015 | Renewal fee patent year 04 | 28.11.2016 | Renewal fee patent year 05 | 27.11.2017 | Renewal fee patent year 06 | 27.11.2018 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2010051042 (INTELLIKINE INC [US], et al) [I] 1-16 * paragraphs [0995] - [0996] * * paragraph [1008] * * page 165, paragraph 868 - page 169; table 1 * * page 140 - page 142; compounds subclass 1-16 *; | [E]WO2013023184 (INTELLIKINE LLC [US], et al) [E] 1-16 * claims 1-37 * * paragraph [0209] *; | [E]WO2014071109 (INFINITY PHARMACEUTICALS INC [US]) [E] 1-16 * paragraph [0039]; compound formula IIIa * * compounds 201, 235, 236, 239, 240, 243, 251, 266, 269, * * paragraphs [0511] - [0512] * * paragraph [0521] * | [IP] - Shunyou Wang, "Abstract 3753: Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer", Cancer Res, doi:10.1158/1538-7445.AM2012-3753, (20120415), URL: http://cancerres.aacrjournals.org/content/72/8_Supplement/3753.short, (20150302), XP055173017 [IP] 1-16 * the whole document * DOI: http://dx.doi.org/10.1158/1538-7445.AM2012-3753 | International search | [X]US2010184760 (REN PINGDA [US], et al); | [Y]EP1880723 (NOVARTIS AG [CH]); | [Y]WO2011062930 (GLAXOSMITHKLINE LLC [US], et al) |